Theravance Biopharma Inc
Change company Symbol lookup
Select an option...
TBPH Theravance Biopharma Inc
ASC Ardmore Shipping Corp
LINK Interlink Electronics Inc
NSPYIEiv.P SPDR MSCI ACWI IMI
AIG American International Group Inc
OII Oceaneering International Inc
ACQRU Independence Holdings Corp
IFPJF Informa PLC
FKWL Franklin Wireless Corp
VTI.IV Vanguard Total Stock Market ETF
Go

Health Care : Pharmaceuticals | Small Cap Growth
Based in Cayman Islands
Company profile

Theravance Biopharma, Inc. is a diversified biopharmaceutical company, which is primarily focused on the discovery, development and commercialization of organ-selective medicines. The Company develops transformational medicines to improve the lives of patients suffering from serious illnesses. The Company's research is focused in the areas of inflammation and immunology. It applies organ-selective knowledge to biologically compelling targets to discover and develop medicines, which are designed to treat underserved localized diseases and to limit systemic exposure. The Company is developing lung-selective medicines to treat respiratory disease, including YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). Its revefenacin is a long-acting muscarinic antagonist (LAMA). Its programs also include Nezulcitinib, Ampreloxetine (TD-9855), Izencitinib, TD-5202 and TD-8236.

Closing Price
$7.11
Day's Change
0.25 (3.64%)
Bid
--
Ask
--
B/A Size
--
Day's High
7.27
Day's Low
6.77
Volume
(Below Average)
Volume:
2,797,693

10-day average volume:
3,241,146
2,797,693
  • Prev Close
    6.86
  • Today's Open
    6.86
  • Day's Range
    6.77-7.27
  • Avg Vol (10-day)
    3.2M
  • Last (time)
    4:00p ET 09/17/21
  • Last (size)
    96
  • 52-Wk Range
    6.10 - 22.74
    LowHigh
  • (04/22/21 - 09/15/21)
    16.56%
  • 66.3%
  • Market Cap
    522.4M
  • Shares Outstanding
    73.5M
  • -4.11
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.9
  • 90.73
  • (% of float 08/31/21)
    3.47

Latest News

September 15, 2021
6:31 am ET
MarketWatch
6:22 am ET
MarketWatch
6:22 am ET
MarketWatch
6:21 am ET
MarketWatch
6:21 am ET
MarketWatch
6:20 am ET
MarketWatch
6:20 am ET
MarketWatch
6:06 am ET
PR Newswire
6:05 am ET
PR Newswire
September 07, 2021
8:10 am ET
MarketWatch
August 24, 2021
8:04 am ET
MarketWatch
August 23, 2021
4:51 pm ET
MarketWatch
4:05 pm ET
PR Newswire
August 03, 2021
4:00 pm ET
PR Newswire
July 20, 2021
6:00 am ET
PR Newswire
June 24, 2021
10:56 pm ET
PR Newswire
4:33 pm ET
PR Newswire
June 21, 2021
6:05 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.